Therefore, the targeted knockdown and silencing of CUL7 has led to a decrease in cell proliferation, weaker −tubulin accumulation in microtubules, promoting their stability and decreasing cell migration (in breast, liver and lung carcinoma cells) and has been suggested as a potential therapeutic target in various cancers47–49. Here, CUL7 is linked to lung carcinoma.